Skip to Main Content
Back to News

Lobbying Update: $40,000 of MERCK & CO. INC. lobbying was just disclosed

None

$40,000 of MERCK & CO. INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals. H.R.1, One Big Beautiful Bill Act (P.L.119-21), all bio-pharmaceutical related provisions. Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2026 National Defense Authorization Act, S.2296/H.R.3838), antimicrobial resistance, VICP Program, PBM reform, vaccine schedule and vaccine safety; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; Inflation Reduction Act of 2022 (P.L.117-169) implementation; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation. Issues related to tax reform; R&D tax credit; international taxation; Inflation Reduction Act of 2022 (P.L.117-169) implementation; H.R.1, One Big Beautiful Bill Act (P.L.119-21)."

You can find more data on corporate lobbying on Quiver Quantitative.

MRK Congressional Stock Trading

Members of Congress have traded $MRK stock 14 times in the past 6 months. Of those trades, 6 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $MRK stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MRK Hedge Fund Activity

We have seen 1,431 institutional investors add shares of MRK stock to their portfolio, and 1,743 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MRK Price Targets

Multiple analysts have issued price targets for $MRK recently. We have seen 5 analysts offer price targets for $MRK in the last 6 months, with a median target of $90.0.

Here are some recent targets:

  • Geoff Meacham from Citigroup set a target price of $95.0 on 10/13/2025
  • Luisa Hector from Berenberg set a target price of $90.0 on 09/17/2025
  • Mohit Bansal from Wells Fargo set a target price of $90.0 on 07/30/2025
  • Terence Flynn from Morgan Stanley set a target price of $98.0 on 07/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles